Epicareer Might not Working Properly
Learn More
Back

Acceleron Pharma, Inc.

About the Company

Acceleron Pharma Inc. is a biopharmaceutical company that focuses on developing therapies for serious and rare diseases. Founded in 2003, the company has been dedicated to discovering, developing, and commercializing novel therapeutics that can improve the lives of patients. Acceleron's pipeline includes various programs targeting different diseases, including pulmonary arterial hypertension, beta-thalassemia, and Duchenne muscular dystrophy. The company's lead product candidate, sotatercept, is currently in clinical trials for multiple indications. Acceleron has collaborations with major pharmaceutical companies, including Celgene and Bristol-Myers Squibb, to develop and commercialize its products. The company is headquartered in Cambridge, Massachusetts, and employs over 300 people.

Industry Type

According to the GICS (Global Industry Classification Standard) version of March 2023, Acceleron Pharma, Inc.’s industry classification falls within the following categories:
  • Sector: Health Care
  • Industry group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Life Sciences Tools & Services
  • Sub-Industry: Life Sciences Tools & Services
Videos and Photos

Company Address

126 East Lincoln Avenue Rahway, NJ 07065 United States

Source : Google maps